Top Menu

Author Archive | admin

Pfizer-BioNTech

Pfizer, BioNTech Announce Final Efficacy Analysis from Phase 3 Study of their COVID Vaccine Candidate

Early this morning, Pfizer and BioNTech issued a news release stating that the Phase 3 study of their MRNA-based COVID-19 vaccine met all primary efficacy endpoints. “Analysis of the data indicates a vaccine efficacy rate of 95% (p<0.0001) in participants without prior SARS-CoV-2 infection (first primary objective) and also in participants with and without prior […]

Continue Reading 0
Phreesia1

5th Wave of COVID Tracking Research Released by Phreesia, Harvard, & Commonwealth Fund

In mid-October, the latest wave of research tracking COVID’s impact on outpatient visits was published by Commonwealth Fund, Harvard, and Phreesia. The latest data found that overall outpatient care visits in the prior month have finally returned to prepandemic levels, after dropping nearly 60% during the spring. (This fifth wave data set tracked trends through […]

Continue Reading 0
WP-cover-01

Achieving Results Amid a Pandemic

As a marketing channel, the pharmacy turned challenges into opportunities for Rx brands Pharmacies stepped up to help consumers through the public health crisis. And consumers responded by stepping into pharmacies. That dynamic has been an important part of getting many communities through an unprecedented challenge. And it has also helped pharma marketers reach patients […]

Continue Reading 0
david_linetsky_headshot

One-on-One with Phreesia’s David Linetsky

Sponsored Content In this interview, DTC Perspectives’ Chairman, Bob Ehrlich, and Phreesia’s SVP of Life Sciences, David Linetsky, discuss how the patient experience has evolved rapidly during the COVID-19 pandemic, particularly as providers leverage digital patient intake solutions to enable safer contactless workflows. They will also explore the importance of aligning with platforms that are […]

Continue Reading 0
dv1954038

Genentech Releases Landmark Study on Health Inequity

After consistently seeing an underrepresentation of non-white patients in clinical research, Genentech decided to dig deeper as to why there is such enrollment inequity. According to an announcement from their website, the pharmaceutical manufacturer “undertook a landmark study to elevate the perspectives of these medically disenfranchised individuals and reveal how this long-standing inequity impacts their […]

Continue Reading 0
FDa-Logo-Blue-large-Small-01

Digital Health Center of Excellence Created by FDA

The FDA announced this week the creation of the Digital Health Center of Excellence for the Center for Devices and Radiological Health (CDRH). Its establishment is another step in the agency’s goal for modernizing digital health policies, regulatory approaches, and the advancement of digital health technology – such as mobile health devices, Software as a […]

Continue Reading 0
empty-waiting-room-during-COVID-19_21x9

Phreesia, Commonwealth Fund, & Harvard Issue Newest Research Wave of COVID-19 Impacts on Outpatient Visits

“Visits to physician offices and other health care practices, which had fallen 60 percent by early April, have now rebounded and plateaued at 10 percent below prepandemic levels,” found the latest wave of research from the Harvard University, Phreesia, and the Commonwealth Fund. In-office visits are still showing a decline, even among those states which […]

Continue Reading 0
CMS-toolkit

CMS Aids in Acceleration of Broader Telehealth Adoption

With the rapid use of telehealth resulting from the pandemic, the Centers for Medicare & Medicaid Services (CMS) released a new toolkit to help the Medicaid and Children’s Health Insurance Programs (CHIP) accelerate their adoption of telehealth coverage during this time. The toolkit is designed to walk states through identifying policies that they will need […]

Continue Reading 0